135 INDUSTRIAL DR N MADISON, MS 39110 Get Directions
135 INDUSTRIAL DR N MADISON, MS 39110 Get Directions
Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded, generic and OTC pharmaceutical products. The Company manages a portfolio of branded products, including the recently acquired Hawthorn Pharmaceuticals' product line. The Company's branded products for the pediatrics market include CEDAX(R), an antibiotic for middle ear infections, NATROBA(TM), a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC, and a family of treatments for cough and cold (ZUTRIPRO(R), BROVEX(R), ALDEX(R) and PEDIATEX(R)). The Company's branded products for gastroenterology include OMECLAMOX-PAK(R), a 10-day treatment for H. pylori infection and duodenal ulcer disease, and REZYST(TM), a probiotic blend to promote dietary management. The Company also markets the branded product, SILENOR(R), for the treatment of insomnia. The Company promotes its branded pediatric and gastroenterology products through its sales force. Pernix markets its generic products through its wholly-owned subsidiaries, Cypress Pharmaceutical and Macoven Pharmaceuticals. The Company's wholly-owned subsidiary, Pernix Manufacturing, manufactures and packages products for the pharmaceutical industry in a wide range of dosage forms. Founded in 1996, the Company is based in The Woodlands, TX.
© Dun & Bradstreet, Inc. 2024. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.